相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aerobic exercise ameliorates benign prostatic hyperplasia in obese mice through downregulating the AR/androgen/PI3K/AKT signaling pathway
Sha-sha Wang et al.
EXPERIMENTAL GERONTOLOGY (2021)
Asiatic Acid Interferes with Invasion and Proliferation of Breast Cancer Cells by Inhibiting WAVE3 Activation through PI3K/AKT Signaling Pathway
Xiao-jun Gou et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways
Xinxing Lu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Paljung-San, a traditional herbal medicine, attenuates benign prostatic hyperplasia in vitro and in vivo
Eunsook Park et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Insulin-like growth factor-1 (IGF-1) promotes primordial follicle growth and reduces DNA fragmentation through the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signalling pathway
Maria E. S. Bezerra et al.
REPRODUCTION FERTILITY AND DEVELOPMENT (2018)
Centella asiatica (Gotu kola) as a neuroprotectant and its potential role in healthy ageing
Rasangani Sabaragamuwa et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2018)
Cognitive functions and health-related quality of life in men with benign prostatic hyperplasia and symptoms of overactive bladder when treated with a combination of tamsulosin and solifenacin in a higher dosage
Kirill Kosilov et al.
AGING MALE (2018)
Inhibition effects of chlorogenic acid on benign prostatic hyperplasia in mice
Ya Huang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Asiatic acid exerts anticancer potential in human ovarian cancer cells via suppression of PI3K/Akt/mTOR signalling
Lu Ren et al.
PHARMACEUTICAL BIOLOGY (2016)
Crosstalking between Androgen and PI3K/AKT Signaling Pathways in Prostate Cancer Cells
Suk Hyung Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Increasing homogeneity in global food supplies and the implications for food security
Colin K. Khoury et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Pathogenic role of HIF-1 alpha in prostate hyperplasia in the presence of chronic inflammation
Hye-Jin Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Androgens and estrogens in benign prostatic hyperplasia: Past, present and future
Tristan M. Nicholson et al.
DIFFERENTIATION (2011)
Silodosin Therapy for Lower Urinary Tract Symptoms in Men with Suspected Benign Prostatic Hyperplasia: Results of an International, Randomized, Double-Blind, Placebo- and Active-Controlled Clinical Trial Performed in Europe
Christopher R. Chapple et al.
EUROPEAN UROLOGY (2011)
Pharmacological Review on Centella asiatica: A Potential Herbal Cure-all
Kashmira J. Gohil et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Current status of 5α-reductase inhibitors in the management of lower urinary tract symptoms and BPH
Stavros Gravas et al.
WORLD JOURNAL OF UROLOGY (2010)
Pharmacological effects of saw palmetto extract in the lower urinary tract
Mayumi Suzuki et al.
ACTA PHARMACOLOGICA SINICA (2009)
Pathology of benign prostatic hyperplasia
C. G. Roehrborn
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2008)
Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors
Antonei Csoka et al.
JOURNAL OF SEXUAL MEDICINE (2008)
ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion
Changmeng Cai et al.
MOLECULAR ENDOCRINOLOGY (2007)
Identification of triterpenoid compounds of Centella asiatica by thin-layer chromatography and mass spectrometry
M Bonfill et al.
BIOMEDICAL CHROMATOGRAPHY (2006)
Prevalence and risk factors of lower urinary tract symptoms in Fuzhou Chinese women
WJ Zhang et al.
EUROPEAN UROLOGY (2005)
Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways
J Fang et al.
FASEB JOURNAL (2005)
Epithelial stem cells in human prostate growth and disease
DL Hudson
PROSTATE CANCER AND PROSTATIC DISEASES (2004)
Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician
CR Chapple
BJU INTERNATIONAL (2004)
Molecular and cellular pathogenesis of benign prostatic hyperplasia
KL Lee et al.
JOURNAL OF UROLOGY (2004)
Prostate specific antigen gene regulation by androgen receptor
J Kim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Alpha-blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5α-reductase inhibitor dutasteride
J Barkin et al.
EUROPEAN UROLOGY (2003)
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
CG Roehrborn et al.
UROLOGY (2002)
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis:: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
E Laughner et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Role of androgens and fibroblast growth factors in prostatic development
AA Thomson
REPRODUCTION (2001)
Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia
LS Marks et al.
JOURNAL OF UROLOGY (2000)
Saw palmetto for the treatment of men with lower urinary tract symptoms
GS Gerber
JOURNAL OF UROLOGY (2000)
分享论文
